Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich concentrates can be an alternative treatment for oral lichen planus, especially when steroids don't work.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Testosterone makes the connections in the uterus lining simpler and lowers certain protein levels, which might lead to infertility.

Testosterone reduces heart damage and inflammation after injury.

Cocaine impairs male sexual behavior and alters testosterone metabolism in the brain.

Men generally have higher blood pressure than premenopausal women, but postmenopausal women's blood pressure can surpass men's, and hormone therapy doesn't significantly help.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Chronic stress can reduce skin pigmentation.

Transdermal drug delivery systems are effective and promising for future use.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Platelet-Rich Plasma (PRP) therapy can promote hair growth and improve facial aesthetics, including reducing acne scars and facial burns, and it works best with three initial monthly injections.

New compounds may soon be tested to treat excessive hair growth in women.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Polygonum multiflorum can promote hair growth when taken orally or applied topically.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Minoxidil effectively lowers blood pressure and initially increases plasma renin activity without raising aldosterone levels.

Oral minoxidil effectively controls blood pressure quickly and safely.

Finasteride reduces movement issues in Parkinson's disease rats.